Clinical Trials Directory

Trials / Completed

CompletedNCT03044938

Acute Effect of Salbutamol on Heart Rate and Blood Pressure During Exercise in Patients With Moderate or Severe Asthma and Healthy Subjects

Acute Effect of Salbutamol on Heart Rate and Blood Pressure During Exercise in Patients With Moderate or Severe Asthma and Healthy Subjects: Randomized, Double-blind, and Crossover Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Universidade Ibirapuera · Academic / Other
Sex
All
Age
20 Years – 59 Years
Healthy volunteers
Accepted

Summary

Contextualization: Exercise is a common triggers of bronchospasm in patients with asthma and healthy subjects. To prevent these symptoms frequently they have to use Short-Acting Beta2-Agonists. However, the cardiovascular effects of salbutamol during and after exercise remain poorly known. Objective: To evaluate the effect of salbutamol on heart rate and blood pressure during exercise in patients with moderate or severe asthma and healthy individuals. Methods: A randomized, double-blind, crossover study will be conducted which 13 individuals with moderate or severe persistent asthma and 13 healthy individuals aged between 20 to 59 years. Patients will perform a maximal effort test on 2 nonconsecutive days, with either 400mcg Salbutamol or 4 placebo puffs. The order of use of placebo or salbutamol will be drawn. During the protocol, heart rate, blood pressure, perception of exertion and peak expiratory flow will be monitored.

Conditions

Interventions

TypeNameDescription
DRUGsalbutamolSalbutamol or albuterol is a short-acting β2 adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease.
DRUGPlaceboNeutral preparation for pharmacological effects, given in substitution of a medicine, for the purpose of provoking or controlling reactions, ger. Of a psychological nature, accompanying such a therapeutic procedure.

Timeline

Start date
2016-08-06
Primary completion
2016-08-06
Completion
2016-11-21
First posted
2017-02-07
Last updated
2017-02-07

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03044938. Inclusion in this directory is not an endorsement.